Fight the New Drug Revenue and Competitors

Location

N/A

Total Funding

NonProfit

Industry

Estimated Revenue & Valuation

  • Fight the New Drug's estimated annual revenue is currently $3.5M per year.(i)
  • Fight the New Drug's estimated revenue per employee is $145,833

Employee Data

  • Fight the New Drug has 24 Employees.(i)
  • Fight the New Drug grew their employee count by 0% last year.

Fight the New Drug's People

NameTitleEmail/Phone
1
Art DirectorReveal Email/Phone
2
Creative DirectorReveal Email/Phone
3
Director Marketing and PartnershipsReveal Email/Phone
4
Director VideographyReveal Email/Phone
5
Marketing and Social Media ManagerReveal Email/Phone
6
Office Manager and Executive AssistantReveal Email/Phone
7
Podcast DeveloperReveal Email/Phone
8
Senior Executive AssistantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$3.5M240%N/AN/A
#2
$15M29-17%N/AN/A
#3
$15M112-10%N/AN/A
#4
$7.5M876%N/AN/A
#5
$15M33-6%N/AN/A
#6
N/A34-3%N/AN/A
#7
$300M2250-2%N/AN/A
#8
N/A15-6%N/AN/A
#9
$7.5M1214%N/AN/A
#10
$3.5M587%N/AN/A
Add Company

What Is Fight the New Drug?

Dropping knowledge on the harmful effects of pornography since '08. Fight the New Drug is a 501(c)(3) nonprofit organization with the mission to educate and raise awareness on the harmful effects of pornography and sexual exploitation. We exist to provide individuals, especially teens, with the opportunity to make an informed decision regarding pornography by raising awareness using science, facts, and personal accounts. Fight the New Drug is comprised of artists, writers, designers, filmmakers, and other creatives seeking to create a movement of change and raise awareness in society through creative mediums.

keywords:N/A

N/A

Total Funding

24

Number of Employees

$3.5M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Fight the New Drug News

2022-04-20 - Opinion | Boss Trump, ‘the Sorest Loser of All Time’

“Trump's Allies Keep Up Fight to Nullify Vote” (front page, ... Neither new patents nor new drugs necessarily equal real innovation.

2022-04-20 - UAB joins international drug trial in fight against ALS

The new study will look at masitinib, an oral medication given in concert with the current standard of care, a drug called riluzole. Masitinib...

2022-04-17 - UAB joins international drug trial in fight against ALS

Preliminary studies reported last year indicate the drug, masitinib, may help prolong overall survival by up to two years. The new study will...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$3.7M249%N/A
#2
$6M240%N/A
#3
$4.9M244%N/A
#4
$1.7M2450%N/A
#5
$3M244%$35.4M